News
Graft vs. host disease (GVHD) is a serious condition that can occur after a stem cell transplant from a donor, where the ...
A late-stage clinical study showed that this weight loss drug helped 2 out of 3 people with the life-threatening liver ...
There is no standard of care for fibrolamellar liver cancer, no targeted therapies. But that may be changing, thanks to recent findings by rare cancer researcher Dr. Taran Gujral, head of Fred Hutch's ...
If you observe any alterations in existing skin lesions or the emergence of new ones, it's crucial to seek medical advice.
If you notice any changes in existing lesions or new ones appear, consult a medical professional. “One of the easiest ways to ...
What if a cup of tea could do more than just relax you? Clove tea is packed with essential vitamins, minerals, and ...
Semaglutide effectively treats liver disease in two thirds of patients, new research has found. Results from the ESSENCE ...
The ability to predict well in advance could allow for early intervention and prevention. Researchers have discovered five ...
Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.
A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.
The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.
How one man, along with his care team, turned an all-consuming cancer diagnosis into a management strategy with inspiration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results